Heart Disease News and Research

Latest Heart Disease News and Research

Hologic features minimally invasive technologies at ACOG annual clinical meeting

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is featuring minimally invasive technologies in surgical, diagnostic and skeletal health at The American College of Obstetricians and Gynecologists (ACOG) annual clinical meeting.

From Hologic, Inc. 7 May 2012

Health Canada announces labelling update for Cipralex

Health Canada is informing Canadians of a labelling update for the prescription drug Cipralex (the brand name of the drug escitalopram) regarding a dose-related risk of abnormal heart rhythms. Cipralex is used to treat depression and belongs to a family of drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs).

7 May 2012

Low weight gain reported among women with nausea and vomiting of pregnancy

In one of the largest studies of its kind, clinicians and researchers with Carolinas HealthCare System found that nearly 25% of women with nausea and vomiting of pregnancy (NVP) reported weight gain below recommended levels for their pre-pregnancy body mass index (PPBMI).

7 May 2012

People continue to make unhealthy choices despite best intentions

Humana Inc., one of the nation's leading health and well-being companies, and Reader's Digest, one of America's most recognized brands, today announced results of a nationwide survey that highlights an intriguing fact about health in America - despite our best intentions, Americans continue to make unhealthy choices.

7 May 2012

Attitude and personal behavior control affect children's snacking

Attitudes, relationships, intentions and personal behavior control are all factors that could affect a child's decision in either reaching for an apple or grabbing a bag of chips, according to a new study out of the University of Cincinnati.

7 May 2012

Stereotaxis to raise $18.5M

Stereotaxis, Inc. today announced it has entered into definitive agreements with select institutional investors to raise total gross proceeds of approximately $18.5 million in two financing transactions.

7 May 2012

CardioKinetix Parachute Ventricular Partitioning Device trial data presented at 2012 EuroPCR

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced that clinical trial data from the first-of-its-kind Parachute Ventricular Partitioning Device for the treatment of patients with ischemic heart failure will be presented at the 2012 EuroPCR Conference in Paris.

7 May 2012

First Edition: May 7, 2012

Today's health policy highlights include reports detailing what's ahead this week on Capitol Hill as well as state-level developments.

7 May 2012

Kerberos to put Rinspiration Thrombectomy System up for bid

Co-Founders of Kerberos Proximal Solutions, Inc., announced today that, during the upcoming Paris Course on Revascularization, they plan to actively engage in discussions to put the company's proprietary Rinspiration technology platform up for bid, seeking buyers with complementary portfolios and distribution channels.

7 May 2012

New process cells use to produce proteins in low-oxygen environments

"How do bodily cells function when we are at a high altitude where the air contains little oxygen?"

7 May 2012

No functional difference in effects of Lucentis and Avastin on preventing vision loss

The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported today at an international research meeting in Fort Lauderdale, Florida. The findings will also appear online shortly in the leading journal Ophthalmology.

7 May 2012

Researchers make white fat take on characteristics of brown fat

Brown seems to be the color of choice when it comes to the types of fat cells in our bodies. Brown fat expends energy, while its counterpart, white fat stores it. The danger in white fat cells, along with the increased risk for diabetes and heart disease it poses, seems especially linked to visceral fat. Visceral fat is the build-up of fat around the organs in the belly.

7 May 2012

Seattle Children's Hospital performs 100th heart transplant on 5-month-old baby

On Saturday, April 28, a 5-month-old baby received the 100th heart transplant performed at Seattle Children's Hospital, a significant milestone for him as well as the hospital's Heart Center and Heart Transplant Program teams.

7 May 2012

AHA recognizes HHS’ Charla de Lupus program with HAVE

The American Hospital Association (AHA) has recognized Hospital for Special Surgery's Charla de Lupus (Lupus Chat) program with its Hospital Award for Volunteer Excellence.

5 May 2012

Human stem cells effective in treating muscular dystrophy

Researchers from the University of Minnesota's Lillehei Heart Institute have effectively treated muscular dystrophy in mice using human stem cells derived from a new process that - for the first time - makes the production of human muscle cells from stem cells efficient and effective.

5 May 2012

Accellent to sell Pittsburgh facility to Perryman

Accellent Inc., a wholly-owned subsidiary of Accellent Holdings Corp., has entered into an agreement to sell its facility located just outside of Pittsburgh in Houston, Pennsylvania to The Perryman Company, also headquartered in Houston, Pennsylvania. Substantially all of the Facility's employees will become employees of Perryman effective upon completion of the sale, which is expected to be completed during the second quarter of 2012.

5 May 2012

PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue

Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in this process. They succeeded in reducing tumour growth in their experiments by blocking the phosphodiesterase PDE4.

5 May 2012

Sound Interventions completes ultrasound clinical trial on resistant hypertension

Sound Interventions, Inc. today announced the successful completion of the company's First-In-Human clinical trial (SOUND-ITV) to treat resistant hypertension.

5 May 2012

TCFC completes two in-utero fetal cardiac interventions to treat HLHS

The team at Texas Children's Fetal Center, a national leader for treating fetal anomalies, has successfully completed two in-utero fetal cardiac interventions to treat hypoplastic left heart syndrome (HLHS), a congenital heart defect that is one of the most complex heart defects to treat.

5 May 2012

HIMSS Analytics recognizes 17 Banner Health facilities with Stage 7 award

Seventeen Banner Health facilities have achieved Stage 7, the final stage in the adoption of electronic medical record (EMR) as acknowledged by HIMSS Analytics, a wholly owned nonprofit subsidiary of the Healthcare Information and Management Systems Society.

5 May 2012